New CLIA e-Notifications: Here’s What Clinical Labs Need to Know
As of March 1, 2026, CMS will move CLIA away from paper-based transactions to improve efficiency and payments
CMS-nir
Subscribe today for access to
Articles and Reports
LDT Oversight Remains Under CLIA, for Now
Judge rules that the FDA has ‘no authority’ to issue its rule governing laboratory-developed tests
Further Details to Note about Updated Clinical Lab Director Qualifications
Put into place late last year, the new rules place more emphasis on formal and continuing education requirements
CMS to Hold Public Meeting on Lab Fee Schedule Updates
...
Already a member? Log in here
Pathologists Exempt From 2015 Meaningful Use Penalty
...
Already a member? Log in here
CMS to Cover Hepatitis C Screening In Eligible Adults
...
Already a member? Log in here
Medicare Seeks Input on More Than 100 New Lab Test Codes
...
Already a member? Log in here
Aetna Cuts Pathology Reimbursement To 70% of Medicare
...
Already a member? Log in here
Colon Cancer Screening Test Gets FDA Approval, Proposed Medicare Coverage
...
Already a member? Log in here
FDA Plans to Regulate Lab-Developed Tests Could Increase Time and Cost of Development
In its July 31 notice to Congress, the agency says it would phase in oversight requirements over nine years.
Labs Finalizing Policies and Procedures Under Patient Access Rule
...
Already a member? Log in here